XML 95 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
Income Taxes
12 Months Ended
Oct. 03, 2014
Income Taxes [Abstract]  
Income Taxes

6INCOME TAXES

The U.S. and foreign income before income taxes for the respective years consisted of the following:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2014

2013

2012

United States

$

11,592 

$

19,885 

$

20,332 

Foreign

 

5,830 

 

4,775 

 

(406)

 

$

17,422 

$

24,660 

$

19,926 

 

 

 

 

 

 

 

 

Income tax expense for the respective years consisted of the following:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2014

2013

2012

Current:

 

 

 

 

 

 

Federal (net of tax benefit from operating loss carryforward of $0,  $0 and $3,098, respectively)

$

3,888 

$

2,832 

$

828 

State

 

403 

 

470 

 

378 

Foreign

 

1,886 

 

1,437 

 

1,595 

Deferred

 

2,122 

 

594 

 

6,991 

 

$

8,299 

$

5,333 

$

9,792 

 

 

 

 

 

 

 

The tax effects of temporary differences that give rise to deferred tax assets and deferred tax liabilities at the end of the respective years are presented below: 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2014

2013

 

Deferred tax assets:

 

 

 

 

 

 

Inventories

$

1,809 

$

1,974 

 

 

Compensation

 

10,362 

 

7,074 

 

 

Tax credit carryforwards

 

3,462 

 

6,385 

 

 

Net operating loss carryforwards

 

7,333 

 

7,215 

 

 

Other

 

4,635 

 

5,109 

 

 

Total gross deferred tax assets

 

27,601 

 

27,757 

 

 

Less valuation allowance

 

8,734 

 

9,479 

 

 

Deferred tax assets

 

18,867 

 

18,278 

 

 

Deferred tax liabilities:

 

 

 

 

 

 

Goodwill and other intangibles

 

989 

 

1,279 

 

 

Depreciation and amortization

 

4,795 

 

1,091 

 

 

Foreign statutory reserves

 

503 

 

1,114 

 

 

Net deferred tax assets

$

12,580 

$

14,794 

 

 

 

 

 

 

 

 

 

 

The net deferred tax assets recorded in the accompanying Consolidated Balance Sheet as of the years ended October 3, 2014 and September 27, 2013 were as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2014

2013

 

Current assets

$

8,360 

$

7,869 

 

 

Non-current assets

 

5,353 

 

8,039 

 

 

Non-current liabilities

 

1,133 

 

1,114 

 

 

Net deferred tax assets

$

12,580 

$

14,794 

 

 

 

 

 

 

 

 

 

 

The significant differences between the statutory federal tax rate and the effective income tax rates for the Company for the respective years shown below were as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2014

2013

2012

Statutory U.S. federal income tax rate

 

35.0 

%

35.0 

%

35.0 

%

Foreign rate differential

 

(0.5)

 

(4.1)

 

(1.0)

 

State income tax, net of federal benefit

 

4.4 

 

4.5 

 

3.1 

 

Tax credit

 

(6.3)

 

(3.1)

 

 -

 

Deferred tax asset valuation allowance

 

(4.3)

 

(11.5)

 

7.1 

 

Unrecognized tax benefit

 

5.4 

 

 -

 

 -

 

Goodwill impairment

 

10.4 

 

 -

 

 -

 

Other

 

3.6 

 

0.8 

 

4.9 

 

 

 

47.7 

%

21.6 

%

49.1 

%

 

 

 

 

 

 

 

 

The Company’s net operating loss carryforwards and their expirations as of October 3, 2014 were as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

State

United States

Foreign

Total

Year of expiration

 

 

 

 

 

 

 

 

2015-2019

$

2,158 

$

 -

$

1,104 

$

3,262 

2020-2024

 

1,182 

 

 -

 

2,262 

 

3,444 

2025-2029

 

5,672 

 

 -

 

2,034 

 

7,706 

2030-2034

 

30,074 

 

 -

 

774 

 

30,848 

Indefinite

 

 -

 

 -

 

8,535 

 

8,535 

Total

$

39,086 

$

 -

$

14,709 

$

53,795 

 

 

 

 

 

 

 

 

 

The Company has tax credit carryforwards comprised of foreign tax credits, research and development and other state credits as shown in the table below.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

State

Federal

Total

Year of expiration

 

 

 

 

 

 

2015-2019

$

767 

$

 -

$

767 

2020-2024

 

1,111 

 

970 

 

2,081 

2025-2029

 

614 

 

 -

 

614 

2030-2034

 

 -

 

 -

 

 -

Indefinite

 

 -

 

 -

 

 -

Total

$

2,492 

$

970 

$

3,462 

 

 

 

 

 

 

 

Under generally accepted accounting principles, the Company considers at each reporting period all available evidence, both positive and negative, to determine whether, based on the weight of that evidence, a valuation allowance is needed to reduce its deferred tax asset to an amount that is more likely than not to be realized.  The determination of the need for a valuation allowance for the deferred tax assets is dependent upon management’s evaluation of both positive and negative evidence.  Positive evidence includes the probability of achieving forecasted future taxable income, applicable tax strategies and assessments of the current and future economic and business conditions.  Negative evidence includes the Company’s cumulative losses and expiring tax carryforwards.  

 

For 2014, the negative impact to the income tax expense and primary increase to the effective tax rate was the result of the impairment charge against goodwill as discussed in Note 18.  The Company had no tax value in the goodwill which resulted in no tax benefit received from the impairment charge against it.

 

The impact of the valuation allowance in fiscal 2014 of $745 of tax benefit was primarily the result of earnings in Italy, Netherlands, Spain and United Kingdom offsetting operating losses in France, Japan and New Zealand.  The Company believes the negative evidence continues to outweigh the positive evidence and as such, the valuation allowance will remain in place.

 

For 2013, the positive impact of the valuation allowance in the amount of $2,831 on tax expense was primarily the result of the expected usage of foreign tax credits of $3,076, offset in part by increases in foreign valuation allowances of $244.  Operating losses in France, Netherlands, New Zealand and the United Kingdom were partially offset by income in Italy, Spain and Japan.

 

The change in the valuation allowance in 2012 provided a negative impact of $1,410 to the effective tax expense.  This amount was primarily the result of increases in foreign valuation allowances of $1,787, which were partially offset by U.S. usage of tax attributes totaling $377.  In fiscal 2012, the Company established a valuation allowance of $173 against the net deferred tax assets in the New Zealand tax jurisdiction based on a cumulative earnings deficit.  Additional operating losses in France, Japan, Italy, Spain and United Kingdom also increased the valuation allowance by $1,614 in fiscal 2012.

 

Taxes paid were $6,581,  $2,399 and  $3,163 for 2014, 2013 and 2012, respectively. 

 

The decrease in deferred tax assets due to utilization of U.S. federal net operating loss carryforwards was $0,  $0 and $5,260 for 2014, 2013 and 2012, respectively.

 

In accordance with its accounting policy, the Company recognizes accrued interest and penalties related to unrecognized tax benefits as a component of income tax expense. The total accrued interest and penalties with respect to income taxes was approximately $778 and $592 for the years ended October 3, 2014 and September 27, 2013, respectively.  Interest and penalties of $186,  $21 and $184 was recorded as a component of income tax expense (benefit) in the accompanying Consolidated Statements of Operations during fiscal years 2014, 2013 and 2012, respectively. 

 

A reconciliation of the beginning and ending amount of unrecognized tax benefits for the last three fiscal years was as follows:

 

 

 

 

 

 

Balance at September 30, 2011

$

1,684 

Settlement

 

(773)

Lapse of statute of limitations

 

(123)

Gross increases - tax positions in  period

 

1,112 

Balance at September 28, 2012

$

1,900 

Settlement

 

(186)

Lapse of statute of limitations

 

(214)

Gross increases - tax positions in  period

 

655 

Balance at September 27, 2013

$

2,155 

Settlement

 

 -

Lapse of statute of limitations

 

(161)

Gross increases - tax positions in  period

 

1,097 

Balance at October 3, 2014

$

3,091 

 

 

 

The Company has not provided additional U.S. income taxes on $113,266 of undistributed earnings of consolidated foreign subsidiaries included in shareholders’ equity attributable to the Company.  Such earnings could become taxable upon the sale or liquidation of these foreign subsidiaries or upon dividend repatriation.  The Company’s intent is for such earnings to be reinvested by the subsidiaries or to be repatriated only when it would be tax effective through the utilization of foreign tax credits.  It is not practicable to estimate the amount of unrecognized withholding taxes and deferred tax liability on such earnings.  As of October 3, 2014, the Company held approximately $60,135 of cash and cash equivalents in foreign jurisdictions.

 

The Company is currently undergoing examinations in Italy and Germany.  There was a change in unrecognized tax benefits as a result of the settlement of a tax audit in Italy in the year ended September 28, 2012.  The amount of unrecognized tax benefits recognized within the next twelve months may decrease due to expiration of the statute of limitations for certain years in various jurisdictions.  However, it is possible that a jurisdiction may open an audit prior to the statute expiring or one of the above audits may adjust the Company’s tax filings.  At this time, an estimate of the range of the reasonably possible change cannot be made. 

 

The Company files income tax returns, including returns for its subsidiaries, with federal, state, local and foreign taxing jurisdictions. The following tax years remain subject to examination by the respective major tax jurisdictions:

 

Jurisdiction

Fiscal Years

United States

2011-2014

Canada

2010-2014

France

2010-2014

Germany

2009-2014

Italy

2009-2014

Japan

2012-2014

Switzerland

2004-2014